Immuneering Share Price
NASDAQ: IMRX | Micro Cap | HealthcareImmuneering Stock Performance
Immuneering Share Price Today
As of 19 November 2026, Immuneering Corporation Class A's share price is $3.48. The stock opened at $3.56, compared to its previous close of $3.46. During today's trading session, Immuneering Corporation Class A's share price traded between $3.43 and $3.56, with an average price of $3.50. Over the past 52 weeks, the stock has recorded a high of $8.47 and a low of $3.31. In terms of performance, Immuneering Corporation Class A's share price has declined by 39.79% over the last six months and is down 54.63% on a year-on-year basis.
Immuneering Share Price Chart
Immuneering Quarterly Profit & Loss
All figures in USD
Immuneering Annual Profit & Loss
All figures in USD
Immuneering Balance Sheet
All figures in USD Million
Immuneering Cash Flow
All figures in USD Million
About Immuneering
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Immuneering Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $3.81 | $3.48 | -6.70% |
Oct 2026 | $4.11 | $3.73 | -9.25% |
Sep 2026 | $4.92 | $4.11 | -21.34% |
Aug 2026 | $4.13 | $5.22 | +26.51% |
Jul 2026 | $5.10 | $4.13 | -17.23% |
Jun 2026 | $5.65 | $4.99 | -13.67% |
May 2026 | $5.21 | $5.78 | +9.99% |
Apr 2026 | $5.29 | $5.25 | -0.10% |
Mar 2026 | $4.86 | $5.26 | +4.99% |
Feb 2026 | $4.62 | $5.01 | +8.09% |
Jan 2026 | $6.53 | $4.63 | -29.45% |
Dec 2025 | $7.47 | $6.57 | -14.34% |